<p><strong>FIGS, Inc.</strong>（纽约证券交易所代码：FIGS）的股价在过去一个月表现非常出色，涨幅达 28%。过去 30 天的年涨幅达到了非常显著的 86%。</p>
<p>在价格大幅反弹之后，你可能会认为 FIGS 是一只不值得研究的股票，因为其市销率（&#34;P/S&#34;）为 2.5 倍，而美国奢侈品行业中几乎一半的公司市销率低于 0.7 倍。不过，仅仅将市销率表面化是不明智的，因为可能有解释说明其为何如此之高。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>查看我们对 FIGS 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/242206947-ps-multiple-vs-industry-1-dark-2/1762858561862?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/242206947-ps-multiple-vs-industry-1-dark-2/1762858561862"/></p>
<p>纽约证券交易所：FIGS 市销率与行业对比 2025 年 11 月 11 日</p>
<h3>FIGS 的市销率对股东意味着什么？</h3>
<p>FIGS 最近的收入增长与行业保持一致。一个可能性是，市销率之所以高，是因为投资者认为这种温和的收入表现将会加速。你真的希望如此，否则你就为没有特别理由的高价格买单。</p>
<p>想知道分析师如何看待 FIGS 的未来与行业的对比吗？那么，我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
<h2>FIGS 的收入增长趋势如何？</h2>
<p>你唯一会真正感到舒适的情况是，当公司的增长有望超越行业时，才会看到像 FIGS 这样的高市销率。</p>
<p>如果我们回顾过去一年的收入增长，公司实现了 5.9% 的可观增长。最近的良好表现意味着它在过去三年中总共实现了 19% 的收入增长。因此，可以公平地说，最近的收入增长对公司来说是相当可观的。</p>
<p>展望未来，预计未来三年将实现每年 6.8% 的增长，这是十位分析师对公司的估计。同时，行业其他部分的年均增长预测也是 6.8%，这并没有实质性差异。</p>
<p>考虑到这一点，我们发现 FIGS 的市销率高于其行业同行，这一点颇具吸引力。显然，许多投资者对公司的看法比分析师所表明的更为乐观，并且目前不愿意抛售他们的股票。不过，随着这种收入增长水平的持续，进一步的收益将难以实现，最终可能会对股价造成压力。</p>
<h2>最后的总结</h2>
<p>FIGS 股价的大幅反弹使公司的市销率大幅提升。有人认为，在某些行业中，市销率是一个较差的价值衡量标准，但它可以作为一种强有力的商业情绪指标。</p>
<p>鉴于其收入预计将与更广泛的行业保持一致，FIGS 目前的市销率似乎高于预期。收入数据并没有引起轰动，这让我们对公司的高市销率能否在长期内持续产生怀疑。需要积极的变化来证明当前的市销率是合理的。</p>
<p>公司的资产负债表中可能存在许多潜在风险。你可以通过我们的 <strong>免费</strong> 资产负债表分析，对 FIGS 进行六项简单检查，评估主要风险。</p>
<p>如果你对 FIGS 的业务实力 <strong>不确定</strong>，为什么不探索一下我们互动式的股票列表，寻找一些你可能错过的基本面扎实的其他公司呢？</p>

FIGS

<p>FIGS, Inc.（纽约证券交易所代码：FIGS）的股价在过去一个月上涨了 28%，使年涨幅达到了 86%。尽管如此，该公司的市销率（P/S）为 2.5 倍，显著高于奢侈品行业的许多同行。最近的收入增长为 5.9%，与行业趋势一致，但分析师预测未来三年的增长仅为 6.8%。这引发了对 FIGS 高市销率可持续性的担忧，暗示如果收入表现没有改善，该股票可能面临挑战</p>

<p>The <strong>FIGS, Inc.</strong> (NYSE:FIGS) share price has done very well over the last month, posting an excellent gain of 28%. The last 30 days bring the annual gain to a very sharp 86%.</p>
<div class="lb-trans"><p><strong>FIGS, Inc.</strong>（纽约证券交易所代码：FIGS）的股价在过去一个月表现非常出色，涨幅达 28%。过去 30 天的年涨幅达到了非常显著的 86%。</p>
</div><p>Following the firm bounce in price, you could be forgiven for thinking FIGS is a stock not worth researching with a price-to-sales ratios (or &#34;P/S&#34;) of 2.5x, considering almost half the companies in the United States' Luxury industry have P/S ratios below 0.7x. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's as high as it is.</p>
<div class="lb-trans"><p>在价格大幅反弹之后，你可能会认为 FIGS 是一只不值得研究的股票，因为其市销率（&#34;P/S&#34;）为 2.5 倍，而美国奢侈品行业中几乎一半的公司市销率低于 0.7 倍。不过，仅仅将市销率表面化是不明智的，因为可能有解释说明其为何如此之高。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>View our latest analysis for FIGS</p>
<div class="lb-trans"><p>查看我们对 FIGS 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/242206947-ps-multiple-vs-industry-1-dark-2/1762858561862" alt="" original-src="https://images.simplywall.st/asset/chart/242206947-ps-multiple-vs-industry-1-dark-2/1762858561862"/></p>
<p>NYSE:FIGS Price to Sales Ratio vs Industry November 11th 2025</p>
<div class="lb-trans"><p>纽约证券交易所：FIGS 市销率与行业对比 2025 年 11 月 11 日</p>
</div><h3>What Does FIGS' P/S Mean For Shareholders?</h3>
<div class="lb-trans"><h3>FIGS 的市销率对股东意味着什么？</h3>
</div><p>Recent revenue growth for FIGS has been in line with the industry. One possibility is that the P/S ratio is high because investors think this modest revenue performance will accelerate. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.</p>
<div class="lb-trans"><p>FIGS 最近的收入增长与行业保持一致。一个可能性是，市销率之所以高，是因为投资者认为这种温和的收入表现将会加速。你真的希望如此，否则你就为没有特别理由的高价格买单。</p>
</div><p>Keen to find out how analysts think FIGS' future stacks up against the industry? In that case, our <strong>free</strong> report is a great place to start.</p>
<div class="lb-trans"><p>想知道分析师如何看待 FIGS 的未来与行业的对比吗？那么，我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
</div><h2>How Is FIGS' Revenue Growth Trending?</h2>
<div class="lb-trans"><h2>FIGS 的收入增长趋势如何？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/S as high as FIGS' is when the company's growth is on track to outshine the industry.</p>
<div class="lb-trans"><p>你唯一会真正感到舒适的情况是，当公司的增长有望超越行业时，才会看到像 FIGS 这样的高市销率。</p>
</div><p>If we review the last year of revenue growth, the company posted a worthy increase of 5.9%. The solid recent performance means it was also able to grow revenue by 19% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been respectable for the company.</p>
<div class="lb-trans"><p>如果我们回顾过去一年的收入增长，公司实现了 5.9% 的可观增长。最近的良好表现意味着它在过去三年中总共实现了 19% 的收入增长。因此，可以公平地说，最近的收入增长对公司来说是相当可观的。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 6.8% per year as estimated by the ten analysts watching the company. Meanwhile, the rest of the industry is forecast to expand by 6.8% each year, which is not materially different.</p>
<div class="lb-trans"><p>展望未来，预计未来三年将实现每年 6.8% 的增长，这是十位分析师对公司的估计。同时，行业其他部分的年均增长预测也是 6.8%，这并没有实质性差异。</p>
</div><p>With this in consideration, we find it intriguing that FIGS' P/S is higher than its industry peers. Apparently many investors in the company are more bullish than analysts indicate and aren't willing to let go of their stock right now. Although, additional gains will be difficult to achieve as this level of revenue growth is likely to weigh down the share price eventually.</p>
<div class="lb-trans"><p>考虑到这一点，我们发现 FIGS 的市销率高于其行业同行，这一点颇具吸引力。显然，许多投资者对公司的看法比分析师所表明的更为乐观，并且目前不愿意抛售他们的股票。不过，随着这种收入增长水平的持续，进一步的收益将难以实现，最终可能会对股价造成压力。</p>
</div><h2>The Final Word</h2>
<div class="lb-trans"><h2>最后的总结</h2>
</div><p>The large bounce in FIGS' shares has lifted the company's P/S handsomely. It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.</p>
<div class="lb-trans"><p>FIGS 股价的大幅反弹使公司的市销率大幅提升。有人认为，在某些行业中，市销率是一个较差的价值衡量标准，但它可以作为一种强有力的商业情绪指标。</p>
</div><p>Seeing as its revenues are forecast to grow in line with the wider industry, it would appear that FIGS currently trades on a higher than expected P/S. The fact that the revenue figures aren't setting the world alight has us doubtful that the company's elevated P/S can be sustainable for the long term. A positive change is needed in order to justify the current price-to-sales ratio.</p>
<div class="lb-trans"><p>鉴于其收入预计将与更广泛的行业保持一致，FIGS 目前的市销率似乎高于预期。收入数据并没有引起轰动，这让我们对公司的高市销率能否在长期内持续产生怀疑。需要积极的变化来证明当前的市销率是合理的。</p>
</div><p>A lot of potential risks can sit within a company's balance sheet. You can assess many of the main risks through our <strong>free</strong> balance sheet analysis for FIGS with six simple checks.</p>
<div class="lb-trans"><p>公司的资产负债表中可能存在许多潜在风险。你可以通过我们的 <strong>免费</strong> 资产负债表分析，对 FIGS 进行六项简单检查，评估主要风险。</p>
</div><p>If you're <strong>unsure about the strength of FIGS' business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果你对 FIGS 的业务实力 <strong>不确定</strong>，为什么不探索一下我们互动式的股票列表，寻找一些你可能错过的基本面扎实的其他公司呢？</p>
</div>

FIGS 公司（NYSE:FIGS）股价大幅上涨 28%，这引发了人们的担忧